WhatsApp
backNews Article

Navin Fluorine Posts 51% Sales Growth to Rs. 2,235.8 Cr in H1 FY27 Amid Capacity Scaling and New Contracts

Operating EBITDA rises 69% to Rs. 764.5 Cr; Key projects including HFC capacity expansion and Chemours contract on track for commissioning in FY27

Navin Fluorine International Limited delivered strong H1 FY27 financial results, reporting Rs. 2,235.8 crore in sales and Rs. 764.5 crore in operating EBITDA, driven by volume growth and price improvements across its core business segments. The company is progressing on key capacity expansions including HFC and specialty chemicals, with new contracts and capex projects advancing on schedule, highlighting healthy demand visibility and product pipeline development.

11 Nov 2026|NAVINFLUOR+0.71%
Navin Fluorine International Limited532504NAVINFLUORInvestor Presentation

Navin Fluorine International Limited

Investor Presentation

Navin Fluorine International Limited reported strong half-year financial performance for the six months ended September 30, 2026, with sales rising 51% year-over-year to Rs. 2,235.8 crore and operating EBITDA increasing by 69% to Rs. 764.5 crore. The growth was supported by higher volumes, improved pricing, and major contracts such as an extended supply deal with Solstice Advanced Materials.

The company’s operating profit before tax (PBT) doubled, reaching Rs. 619.2 crore, supported by a 367 basis point improvement in EBITDA margin to 34.2%.

Revenue growth was driven by all major business verticals: High Performance Products (HPP) segment recorded Rs. 1,144 crore (+41% YoY), Specialty Chemicals Rs. 673 crore (+53% YoY), and Contract Development and Manufacturing Organization (CDMO) Rs. 419 crore (+80% YoY).

In Q2 FY27 alone, sales were Rs. 1,190.7 crore (+57% YoY), with operating EBITDA of Rs. 407.5 crore and operating PBT of Rs. 336 crore, reflecting continued strong quarterly performance.

Strategically, Navin Fluorine is advancing key projects including capital expenditure on new HFC capacity equivalent to 15,000 MTPA of R32, expected to be commissioned soon, and the Chemours project targeted for completion by end of Q3 FY27.

The company extended its HFO supply contract with Solstice Advanced Materials US, Inc. by 4 years, increasing potential revenue by approximately $180 million, taking total contract value to around $590 million over 11 years, supporting long-term revenue visibility.

Highlights

  • H1 FY27 sales rose to Rs. 2,235.8 crore, up 51% from prior year
  • Operating EBITDA increased 69% YoY to Rs. 764.5 crore with 34.2% margin
  • HFC capacity capex on track to add 15,000 MTPA of R32 production
  • HFO supply contract with Solstice advanced by 4 years totaling $590 million value
  • Chemours specialty chemicals project expected to complete by Q3 FY27
  • CDMO segment revenue grew 80% YoY to Rs. 419 crore, supported by new molecule pipeline and engagement with European clients

Key Data Snapshot

H1 FY27 SalesRs. 2,235.8 Cr
H1 FY27 Operating EBITDARs. 764.5 Cr
H1 FY27 Operating EBITDA Margin34.2%
H1 FY27 Operating PBTRs. 619.2 Cr
Q2 FY27 SalesRs. 1,190.7 Cr
Q2 FY27 Operating EBITDARs. 407.5 Cr
Q2 FY27 Operating PBTRs. 336.0 Cr
HFO Supply Contract Value with Solstice Advanced Materials~$590 million over 11 years
Additional HFC Capacity CapexEquivalent upto 15,000 MTPA of R32
Chemours Project CapexRs. 120 Crs
Renewable Power Energy Adoption InvestmentRs. 15.73 Crs
Renewable Power Project Energy CoverageOver 60% of energy needs from renewable sources

Financial performance

  • H1 FY27 revenue increased 51% year-over-year to Rs. 2,235.8 crore driven by volume growth and price improvements.
  • Operating EBITDA rose 69% to Rs. 764.5 crore with margin expansion of 367 basis points to 34.2%.
  • Operating profit before tax nearly doubled, reaching Rs. 619.2 crore, up 93% year-over-year.
  • Q2 FY27 results similarly strong with Rs. 1,190.7 crore revenue and Rs. 407.5 crore operating EBITDA.
  • All business verticals showed significant revenue increases: HPP +41%, Specialty Chemicals +53%, and CDMO +80% year-over-year.

Operational performance

  • Increased volume and improved realisations contributed to growth in High Performance Products (HPP).
  • Pricing for HFC remained firm with quarter-on-quarter price increases.
  • New supply contract with Solstice Advanced Materials extended by 4 years from initial 7-year term, with total contract value around $590 million.
  • Chemours specialty chemicals project targeted for completion by end of Q3 FY27, supporting growth in Specialty Chemicals vertical.
  • CDMO segment expanded with positive developments across key molecules and strategic engagements with European clients.
  • Phase II cGMP4 CDMO capacity expansion of Rs. 125 crore expected operational by end Q4 FY27.
  • Renewable power project investment of Rs. 15.73 crore will supply over 60% of company’s energy needs from renewable sources.

Strategic context

  • Capex underway for additional HFC capacity to manufacture up to 15,000 MTPA of R32, with commissioning expected shortly.
  • Chemours project and Specialty Chemicals capacity enhancements including de-bottlenecking at Dahej site are on schedule.
  • Company is incubating new advanced materials vertical focusing on data centers, electronics, defense and semiconductors applications.
  • Strong global demand and transition towards low GWP refrigerants underpin growth opportunities.
  • Long-term contracts and pipeline molecules support sustained revenue visibility.
  • Company is advancing strategic renewable energy adoption and sustainability efforts.

Next milestones

  • Commissioning of new HFC capacity planned for shortly following capex completion.
  • Completion of Chemours Specialty Chemicals project targeted by end of Q3 FY27.
  • Operationalization of Phase II cGMP4 CDMO expansion targeted by end of Q4 FY27.
  • Ongoing delivery of Solstice Advanced Materials supply contract with expanded term.
  • Continued scaling of new product pipelines and commercial capacities across business verticals.

More News on Investor Presentation

View all

Latest corporate announcements and market updates in Investor Presentation.

View all news
Navin Fluorine Posts 51% Sales Growth to Rs. 2,235.8 Cr | Stockk News